Most Read Articles
Roshini Claire Anthony, 4 days ago

Individuals with moderate-to-severe plaque psoriasis may reap better long-term improvements in the severity of their condition when treated with guselkumab over secukinumab, according to findings of the phase III ECLIPSE* trial presented at the recent Inflammatory Skin Disease Summit (ISDS 2018) held in Vienna, Austria.

Jairia Dela Cruz, 11 Jan 2019
Use of standard-dose aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) appears to confer protection against the risk of endometrial cancer in overweight and obese women, according to a meta-analysis.
Elvira Manzano, 5 days ago
Treatment with two investigational, oral JAK inhibitors may be beneficial in individuals with moderate‐to‐severe alopecia areata (spot baldness), an autoimmune disease that can cause a lot of anxiety, according to an ongoing phase II study.
3 days ago
Discontinuing the use of tyrosine kinase inhibitors (TKIs) in the treatment of patients with chronic myeloid leukaemia appears to be feasible in real-life clinical practice in the context of close molecular monitoring, a study reports.

Female hormone linked to all-cause mortality among elderly men

22 Jul 2018

There appears to be a nonlinear relationship between total oestradiol (tE2) and free oestradiol (fE2) and all-cause mortality among older men, according to data from the Three-City cohort study. Specifically, the association is stronger for cardiovascular disease mortality and nonexistent for cancer mortality.

The Three-City cohort included 3,650 men aged ≥65 years who were followed for over 12 years for mortality. Baseline tE2 was measured, and fE2 was estimated using Vermeulen and Södergard algorithms. Oestrogen receptor (ER) was genotyped in a random subsample of 472 men without hormonal treatment.

Mortality data were drawn from death certificates. Inverse probability weighted Cox models were used to evaluate the association of oestradiol with all‐cause and cause‐specific mortality, and its interaction with ER genetic polymorphisms.

During the follow-up, 183 men died from CVD (n=44), cancer (n=57) or other causes (n=82). A quadratic relationship emerged between all‐cause mortality and tE2 and fE2 (p=0.04 and p=0.05, respectively). The risk of death was higher for the top and bottom tertiles compared to the middle one.

The association was pronounced for CVD mortality (p=0.01 for tE2; p=0.02 for fE2) and disappeared for cancer mortality. No evidence of an interaction between oestradiol and any ER polymorphisms on all‐cause mortality was observed.

Researchers cited several potential mechanisms underlying the association between endogenous oestradiol and CVD mortality. First, high or low endogenous oestradiol could be linked to a worse profile of traditional cardiovascular risk factors, including obesity, diabetes and hypercholesterolemia. Second, the possibility of the involvement of inflammation and hypercoagulability. Third, the association may partly reflect the role of testosterone, given that oestradiol and testosterone levels are correlated.

Although more studies are needed to elucidate the mechanisms, the results of the study could help improve the understanding of the role of oestradiol in men’s health, researchers said.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 4 days ago

Individuals with moderate-to-severe plaque psoriasis may reap better long-term improvements in the severity of their condition when treated with guselkumab over secukinumab, according to findings of the phase III ECLIPSE* trial presented at the recent Inflammatory Skin Disease Summit (ISDS 2018) held in Vienna, Austria.

Jairia Dela Cruz, 11 Jan 2019
Use of standard-dose aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) appears to confer protection against the risk of endometrial cancer in overweight and obese women, according to a meta-analysis.
Elvira Manzano, 5 days ago
Treatment with two investigational, oral JAK inhibitors may be beneficial in individuals with moderate‐to‐severe alopecia areata (spot baldness), an autoimmune disease that can cause a lot of anxiety, according to an ongoing phase II study.
3 days ago
Discontinuing the use of tyrosine kinase inhibitors (TKIs) in the treatment of patients with chronic myeloid leukaemia appears to be feasible in real-life clinical practice in the context of close molecular monitoring, a study reports.